Innovations in CAR-T Cell Therapy

This chapter explores the intricacies and challenges of autologous CAR-T cell therapies, emphasizing the need for efficient manufacturing and administration processes. It highlights the innovative use of lentiviral vectors for in vivo delivery, the importance of targeting strategies, and historical developments in CAR-T therapies. The discussion also covers the impact of market dynamics and the company's strategic decisions for scaling up production amidst evolving challenges.